Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol in Heart Failure Patients
NCT02598505Phase 3Completed
- Sponsor
- Centro Cardiologico Monzino
- Start
- Sep 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indacaterol in heart failure (HF), sponsored by Centro Cardiologico Monzino. Started Sep 2015; status: completed.
02
Drugs
indacaterol
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02598505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02598505.